Steinhoff International Holdings NV
F:SNH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Steinhoff International Holdings NV
F:SNH
|
ZA |
|
N
|
NewAmsterdam Pharma Company NV
DUS:KH6
|
NL |
|
C
|
Carel Industries SpA
XBER:CIG
|
IT |
|
Republic Airways Holdings Inc
F:M2A0
|
US |
|
M
|
Morimatsu International Holdings Co Ltd
F:1S5
|
CN |
|
Cobram Estate Olives Ltd
OTC:CBOAF
|
AU |
|
Mayne Pharma Group Ltd
OTC:MAYNF
|
AU |
|
A
|
Allied Technologies Ltd
SGX:A13
|
SG |
|
Australian Oil Company Ltd
ASX:AOK
|
AU |
|
K
|
Kontoor Brands Inc
F:3KO
|
US |
|
O
|
Oji Holdings Corp
DUS:OJI
|
JP |
|
Oji Holdings Corp
OTC:OJIPF
|
JP |
|
O
|
Ordina NV
F:ORA
|
NL |
|
R
|
Ryohin Keikaku Co Ltd
OTC:RYKKF
|
JP |
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
I
|
iRhythm Technologies Inc
F:I25
|
US |
|
Teekay Corp
NYSE:TK
|
BM |
Wall St Price Targets
SNH Price Targets Summary
Steinhoff International Holdings NV
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNH's stock price target?
Not Available
SNH does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Steinhoff International Holdings NV?
Projected CAGR
14%
Over the last 8 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 14%.
What is the Operating Income forecast for Steinhoff International Holdings NV?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 5 years is 20%.